Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9242969 Biaryl amide compounds as kinase inhibitors

Patent 9242969 was granted and assigned to Novartis on January, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novartis

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9242969

Patent Inventor Names

Savithri Ramurthy0

Valery Polyakov0

Yan Lou0

Gisele Nishiguchi0

Aaron Smith0

Alan DiPesa0

Alice Rico0

Benjamin Taft0

...

Date of Patent

January 26, 2016

Patent Application Number

14204823

Date Filed

March 11, 2014

Patent Citations Received

‌

US Patent 11820766 Monoacylglycerol lipase modulators

‌

US Patent 12011449 Therapeutic combinations comprising a c-RAF inhibitor

‌

US Patent 11839663 Radiolabelled MGL pet ligands

‌

US Patent 11820770 P2X7 modulators

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The present invention provides compounds of Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9242969 Biaryl amide compounds as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API